Omega Speedmaster Apollo 11 45th Anniversary
Pfizer may not give up on AstraZeneca
Commenter 7: There aren't many people who have good things to say about Valeant and their approach in the industry including their own employees and customers. The rich get richer, and thousands of people lose their jobs. It's truly sad.
Here is a compilation of some rather heated comments on the potential takeover of Allergan by Valeant.
Commenter 6: Don't do it Allergan! You're too good for them!
Valeant Pharmaceuticals (VRX) on June 2 readied to take its $53.8 billion takeover bid for Allergan Inc. (AGN) directly to Omega Speedmaster Apollo 11 45th Anniversary shareholders. Allergan wants its shareholders to hold off on any decision until its board has a chance to evaluate the offer and provide a recommendation. Valeant ally Pershing Square, a hedge fund that owns 9.7 percent of Allergan, called for a meeting to replace the company's board that could take place as early as Aug. 7, or if Allergan gets its way, it could be delayed to November. Some believe that a delay in the meeting could benefit Valeant to allow for an increase in their stock price, and hence increase the attractiveness of the offer to help seal the deal.
Commenter 3: Where is the thumb down button when you need it?! Patients all over the world will be negatively impacted if this goes through.
dermatology space Omega Constellation On Wrist
says a lot, without actually saying anything. Bunch of gangsters and bullies!!!
Here is a sampling of what fellow BioSpacers thought about the Pfizer and AstraZeneca saga.
Commenter 7: Another one bites the dust.
Commenter 4: AZ does not need Pfizer. Pfizer has a weak pipeline and needs AZ!
Commenter 5: Would be a huge mistake and a sad day for the medical aesthetic industry! Stay strong Allergan!
Commentary BioSpace Readers Sound Off On Big Pharma Takeovers
Commenter 3: Nothing good can come from a merger like this. corporate taxes. Pathetic.
Commenter 1: Wish they'd back off they don't care about R or what is best for the patients. Ackman has done a terrible job with other companies he's tried to run in the past, in fact his track record is sub par; this situation would be no different. The facts are overwhelming on the side of Allergan. Let's hope the major shareholders of Allergan realize this and don't go for the quick buck or fall for Ackman's tricks and take a ton of crummy Valeant stock.
Commenter 12: Pfizer has acquired and dismantled three really great companies in Warner Lambert, Pharmacia and Wyeth eliminating over 100,000 jobs, keeping the products that their effective R groups had developed, to provide Pfizer new revenue sources that their own R group had been unsuccessful in doing. I am happy that the AZ CEO has told them so far to stick it.
Commenter 11: I've had enough!
Commenter 8: If you think Pfizer is walking away, then you don't know your history.
Commenter 10: Go TeamAllergan I hope and wish Ackman and Pearson don't succeed. If they do, it will be truly a very sad day for all Allergan's partners (employees, stockholders above all and customers).
Commenter 2: It doesn't matter what any of us think, do or say. Bottom line is: Can the board of directors convince the institutional investors (ie. mutual fund managers) to walk away from $92.50 per share and keep their fingers crossed that AZ will be able to get that kind on ROI on their own?
Commenter 9: If Pfizer goes away then so may your life sustaining technologies, research and medicines. Duh
Commenter 5: AZ has the backing of UK and Swedish governments against the takeover.
Commenter 1: I don't think that any of us are misguided by the media view point. The facts speak for themselves, Pfizer has no pipeline to shout about. They've taken over other pharma companies, laid people off and just stripped the company they just bought. The CEO of Pfizer Omega Seamaster Diver 300m Co-axial 41 Mm Review
(let alone the other specialty areas) take yet another hit from a company that places profit and cost cutting over patient care, innovation for the future, and investment in the practices that treat us all.
Commenter 9: It will literally be a crying shame to see the Omega Seamaster Watch Strap
Pfizer (PFE) recently withdrew its 55 a share, 69bn takeover attempt for British pharmaceutical firm AstraZeneca (AZN). No one is ruling out another takeover bid by Pfizer in the near future, perhaps before the end of the year. Despite the current holding pattern, opinions about the potential for a Pfizer/AstraZenaca merger are still smoldering.
Commenter 8: Go Team Allergan. We are proud to be part of such a great company who care[s] about their patients and employees.
By Linda R. As you will note by the comments included below, that there are a lot of unhappy folks who would rather there just be harmony, rather than hostility in the air.
Commenter 10: On behalf of all past "Pfizer Ann Arbor" employees, good luck AZ!
Omega Speedmaster Apollo 11 45th Anniversary
Omega Speedmaster Co-axial
Copyright 2006–2007 Phoenix Gallery. All rights reserved. Site design by . . . || mccallum design